HomeJim Easton Consortium for Alzheimer’s Drug Discovery and Biomarker Development

Jim Easton Consortium for Alzheimer’s Drug Discovery and Biomarker Development

Jim Easton Consortium - Project 1: Characterizing the Amyloid Beta Protein (1)
Jim Easton Consortium - Project 2: Design and Development of Structure-Based Small Molecule Inhibitors of Amyloid Assembly (1)
Jim Easton Consortium - Project 3: Efficacy of New Drugs Directed against Beta Amyloid using in in vitro and in vivo Models (2)
Jim Easton Consortium - Project 4: Biomarkers in Familial Alzheimer's Disease (FAD) (2)
Jim Easton Consortium - Project 5: Imaging and Genetic Biomarkers for Alzheimer’s Disease (ImaGene) (4)

Teplow, David B., Ph.D.

Center Interim Director, Mary S. Easton Center for Alzheimer's Disease Research at UCLA
Professor of Neurology, David Geffen School of Medicine at UCLA
Director of Biopolymer Laboratory, David Geffen School of Medicine at UCLA
Specialty: Neurology, Alzheimer'sDisease, Dementia, and Memory impairment. Tel: (310) 794-3665
Fax: (310) 794-3148
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Jim Easton Consortium - Project 1: Characterizing the Amyloid Beta Protein Administration NIH Alzheimer's Disease Research Center (ADRC) CADC - Adminstration ADRC - Admistrative Core California Alzheimer's Disease Center (CADC) Jim Easton Consortium for Alzheimer’s Drug Discovery and Biomarker Development Clinical and Pre-Clinical Research